Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1957 1
1959 1
1960 1
1966 1
1968 3
1971 1
1972 1
1973 1
1974 1
1976 2
1977 5
1978 2
1979 5
1980 2
1981 2
1982 2
1983 1
1984 3
1985 7
1986 7
1987 5
1988 7
1989 3
1990 6
1991 4
1992 11
1993 11
1994 9
1995 6
1996 8
1997 4
1998 4
1999 6
2000 13
2001 15
2002 8
2003 12
2004 12
2005 31
2006 35
2007 45
2008 57
2009 64
2010 66
2011 71
2012 73
2013 81
2014 64
2015 97
2016 75
2017 50
2018 67
2019 77
2020 93
2021 91
2022 90
2023 79
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,364 results

Results by year

Filters applied: . Clear all
Page 1
KSHV/HHV8-mediated hematologic diseases.
Cesarman E, Chadburn A, Rubinstein PG. Cesarman E, et al. Blood. 2022 Feb 17;139(7):1013-1025. doi: 10.1182/blood.2020005470. Blood. 2022. PMID: 34479367 Free PMC article. Review.
Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials.
Rubinstein SM, de Zoete A, van Middelkoop M, Assendelft WJJ, de Boer MR, van Tulder MW. Rubinstein SM, et al. BMJ. 2019 Mar 13;364:l689. doi: 10.1136/bmj.l689. BMJ. 2019. PMID: 30867144 Free PMC article.
One study with a low risk of selection bias and powered to examine risk (n=183) found no increased risk of an adverse event (relative risk 1.24, 95% confidence interval 0.85 to 1.81) or duration of the event (1.13, 0.59 to 2.18) compared with sham SMT. ...
One study with a low risk of selection bias and powered to examine risk (n=183) found no increased risk of an adverse event (relative …
CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.
de Thonel A, Ahlskog JK, Daupin K, Dubreuil V, Berthelet J, Chaput C, Pires G, Leonetti C, Abane R, Barris LC, Leray I, Aalto AL, Naceri S, Cordonnier M, Benasolo C, Sanial M, Duchateau A, Vihervaara A, Puustinen MC, Miozzo F, Fergelot P, Lebigot É, Verloes A, Gressens P, Lacombe D, Gobbo J, Garrido C, Westerheide SD, David L, Petitjean M, Taboureau O, Rodrigues-Lima F, Passemard S, Sabéran-Djoneidi D, Nguyen L, Lancaster M, Sistonen L, Mezger V. de Thonel A, et al. Nat Commun. 2022 Nov 16;13(1):7002. doi: 10.1038/s41467-022-34476-2. Nat Commun. 2022. PMID: 36385105 Free PMC article.
Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: Rubinstein-Taybi syndrome (RSTS). The biological pathways underlying these neurodevelopmental defects remain elusive. ...Consequentl …
Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: …
Rubinstein-Taybi syndrome in diverse populations.
Tekendo-Ngongang C, Owosela B, Fleischer N, Addissie YA, Malonga B, Badoe E, Gupta N, Moresco A, Huckstadt V, Ashaat EA, Hussen DF, Luk HM, Lo IFM, Hon-Yin Chung B, Fung JLF, Moretti-Ferreira D, Batista LC, Lotz-Esquivel S, Saborio-Rocafort M, Badilla-Porras R, Penon Portmann M, Jones KL, Abdul-Rahman OA, Uwineza A, Prijoles EJ, Ifeorah IK, Llamos Paneque A, Sirisena ND, Dowsett L, Lee S, Cappuccio G, Kitchin CS, Diaz-Kuan A, Thong MK, Obregon MG, Mutesa L, Dissanayake VHW, El Ruby MO, Brunetti-Pierri N, Ekure EN, Stevenson RE, Muenke M, Kruszka P. Tekendo-Ngongang C, et al. Am J Med Genet A. 2020 Dec;182(12):2939-2950. doi: 10.1002/ajmg.a.61888. Epub 2020 Sep 27. Am J Med Genet A. 2020. PMID: 32985117
Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant disorder, caused by loss-of-function variants in CREBBP or EP300. ...
Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant disorder, caused by loss-of-function variants in CREBBP or EP300. ...
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers.
Rubinstein MP, Williams C, Mart C, Beall J, MacPherson L, Azar J, Swiderska-Syn M, Manca P, Gibney BC, Robinson MD, Krieg C, Hill EG, Taha SA, Rock AD, Lee JH, Soon-Shiong P, Wrangle J. Rubinstein MP, et al. J Immunol. 2022 Mar 15;208(6):1362-1370. doi: 10.4049/jimmunol.2100066. Epub 2022 Feb 28. J Immunol. 2022. PMID: 35228263 Clinical Trial.
N-803 did not cause treatment-emergent serious adverse events (AEs) or grade 3 AEs. ...Our results suggest that N-803 administration can potentiate antitumor immunity....
N-803 did not cause treatment-emergent serious adverse events (AEs) or grade 3 AEs. ...Our results suggest that N-803 administ
Disparities in Pediatric Rheumatic Diseases.
Akinsete AM, Woo JMP, Rubinstein TB. Akinsete AM, et al. Rheum Dis Clin North Am. 2022 Feb;48(1):183-198. doi: 10.1016/j.rdc.2021.09.014. Rheum Dis Clin North Am. 2022. PMID: 34798946 Review.
Optimizing immunotherapy for gynecologic cancers.
Rubinstein MM, Makker V. Rubinstein MM, et al. Curr Opin Obstet Gynecol. 2020 Feb;32(1):1-8. doi: 10.1097/GCO.0000000000000603. Curr Opin Obstet Gynecol. 2020. PMID: 31833942 Free PMC article. Review.
Keloids in Rubinstein-Taybi syndrome: a clinical study.
van de Kar AL, Houge G, Shaw AC, de Jong D, van Belzen MJ, Peters DJ, Hennekam RC. van de Kar AL, et al. Br J Dermatol. 2014 Sep;171(3):615-21. doi: 10.1111/bjd.13124. Epub 2014 Aug 21. Br J Dermatol. 2014. PMID: 25132000 Review.
BACKGROUND: Rubinstein-Taybi syndrome (RSTS) is a multiple congenital anomalies-intellectual disability syndrome. ...The 15 Dutch and 12 U.K. individuals with RSTS with keloids demonstrated that most patients have multiple keloids (n > 1: 82%; n > 5: 30 …
BACKGROUND: Rubinstein-Taybi syndrome (RSTS) is a multiple congenital anomalies-intellectual disability syndrome. ...The 15 Dutch and …
Profiles of autism characteristics in thirteen genetic syndromes: a machine learning approach.
Bozhilova N, Welham A, Adams D, Bissell S, Bruining H, Crawford H, Eden K, Nelson L, Oliver C, Powis L, Richards C, Waite J, Watson P, Rhys H, Wilde L, Woodcock K, Moss J. Bozhilova N, et al. Mol Autism. 2023 Jan 13;14(1):3. doi: 10.1186/s13229-022-00530-5. Mol Autism. 2023. PMID: 36639821 Free PMC article.
METHODS: Profiles of autistic characteristics based on the Social Communication Questionnaire (SCQ) scores were generated for thirteen genetic syndrome groups (Angelman n = 154, Cri du Chat n = 75, Cornelia de Lange n = 199, fragile X n = 297, Prader-W …
METHODS: Profiles of autistic characteristics based on the Social Communication Questionnaire (SCQ) scores were generated for thirteen genet …
1,364 results